Literature DB >> 9520945

Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.

S Kasper1, P C Sheppard, Y Yan, N Pettigrew, A D Borowsky, G S Prins, J G Dodd, M L Duckworth, R J Matusik.   

Abstract

Probasin (PB) gene product is prostate-specific, epithelial cell in origin, and androgen-regulated. A large 12-kb promoter fragment of the PB gene (LPB) was linked to the simian virus 40 (SV40) large T antigen (Tag) deletion mutant (that removes the expression of the small t antigen) to deliver consistently high levels of transgene expression to the transgenic mouse prostate. Seven male founders, their male offspring, and all the male offspring from two female founders developed at least prostatic epithelial cell hyperplasia by 10 weeks of age, indicating that the incidence of transformation was 100%. Tumorigenesis in the LPB-Tag animals progressed in a manner similar to that observed in the human prostate. Initially, multifocal proliferating lesions were detected in the prostatic epithelium, which continued to progress into hyperplasia involving the entire epithelium and then low-grade dysplasia. Reactive stromal proliferation was induced and continued to develop throughout the progression to high-grade dysplasia, carcinoma in situ, and adenocarcinoma. Immunohistochemical studies indicated that most stromal cells stained positively for both androgen receptor and smooth muscle alpha-actin, suggesting that stromal overgrowth largely represented mesenchymal cells that had differentiated into smooth muscle cells. Epithelial cell transformation was accompanied by the down-regulation of differentiated function, as suggested by the loss of dorsolateral prostate-specific secretory proteins. Tumor growth was regarded as androgen-dependent because tumors regressed in animals castrated at 11 weeks of age, and androgen treatment restored both epithelial/stromal cell ratio and tumor growth. Furthermore, small populations of prostatic epithelial cells in castrated animals continued to proliferate, suggesting the potential for androgen-independent growth. Although prostatic metastasis to other organs was not observed, local invasion was detected. In summary, the LPB-Tag animal model is unique in that it is the only model generated with the Tag alone, thereby eliminating any influences of the small t antigen on prostate tumor formation. Moreover, this model undergoes molecular changes similar to those found in human prostate including: (a) the multi-focal nature of tumorigenesis, (b) the progressive histopathologic changes from low- to high-grade dysplasia similar to human prostatic intraepithelial neoplasia, (c) stimulation of reactive stromal proliferation, and (d) the androgen-dependent growth of the primary tumor. Thus, the LPB-Tag prostate tumor model will be useful for studying the sequential mechanisms underlying the development of multistep tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520945

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  37 in total

1.  Anaplastic renal carcinoma expressing SV40 T antigen in a female TRAMP mouse.

Authors:  Erin M Goodwin; Qing Zhong; Catherine S Abendroth; Lindsay K Ward-Kavanagh; Todd D Schell; Timothy K Cooper
Journal:  Comp Med       Date:  2013-08       Impact factor: 0.982

Review 2.  Proton magnetic resonance spectroscopy of the central, transition and peripheral zones of the prostate: assignments and correlation with histopathology.

Authors:  Peter Swindle; Saadallah Ramadan; Peter Stanwell; Simon McCredie; Peter Russell; Carolyn Mountford
Journal:  MAGMA       Date:  2008-09-17       Impact factor: 2.310

Review 3.  The genomic revolution and endocrine pathology.

Authors:  Suzana S Couto; Robert D Cardiff
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

4.  Tumor progression in the LPB-Tag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status.

Authors:  Sarah Mordan-McCombs; Theodore Brown; Wei-Lin Winnie Wang; Ann-Christin Gaupel; Joellen Welsh; Martin Tenniswood
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-27       Impact factor: 4.292

5.  Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.

Authors:  Uddhav P Kelavkar; Wayne Glasgow; Sandra J Olson; Barbara A Foster; Scott B Shappell
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

Review 6.  Current mouse and cell models in prostate cancer research.

Authors:  Xinyu Wu; Shiaoching Gong; Pradip Roy-Burman; Peng Lee; Zoran Culig
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

7.  False-positive TUNEL staining observed in SV40 based transgenic murine prostate cancer models.

Authors:  M D Lawrence; B J Blyth; R J Ormsby; W D Tilley; P J Sykes
Journal:  Transgenic Res       Date:  2013-02-20       Impact factor: 2.788

8.  The loss of TGF-beta signaling promotes prostate cancer metastasis.

Authors:  William H Tu; Tania Z Thomas; Naoya Masumori; Neil A Bhowmick; Agnieszka E Gorska; Yu Shyr; Susan Kasper; Tom Case; Richard L Roberts; Scott B Shappell; Harold L Moses; Robert J Matusik
Journal:  Neoplasia       Date:  2003 May-Jun       Impact factor: 5.715

Review 9.  Genetically engineered mouse models of prostate cancer.

Authors:  Maxime Parisotto; Daniel Metzger
Journal:  Mol Oncol       Date:  2013-02-14       Impact factor: 6.603

10.  Candidate metastasis suppressor genes uncovered by array comparative genomic hybridization in a mouse allograft model of prostate cancer.

Authors:  Yajun Yi; Srinivas Nandana; Thomas Case; Colleen Nelson; Tatjana Radmilovic; Robert J Matusik; Karen D Tsuchiya
Journal:  Mol Cytogenet       Date:  2009-09-26       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.